IP Library Granted Patent US 10,415,042
Granted Patent B2
US 10,415,042 · App. 15/184,940 · Granted Sep 17, 2019

Microorganisms for the production of adipic acid and other compounds

Inventors: Anthony P. Burgard (Bellefonte, PA); Priti Pharkya (San Diego, CA); Robin E. Osterhout (San Diego, CA)
Assignee: Genomatica, Inc.
C12N15/52C12N9/001C12N9/0006C12N9/0008C12N9/1029C12N9/1096C12N9/80C12N9/88C12P7/44C12P7/46C12P7/62C12P13/001C12P13/005C12P13/02C12P17/10C12Y101/01035C12Y102/0101C12Y103/01031C12Y206/01C12Y402/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,415,042
App. No.
15/184,940
Granted
Sep 17, 2019
Kind
B2
Abstract

The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6-aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam.

Claims (17)

1. A non-naturally occurring microbial organism having a 6-aminocaproic acid pathway and an adipyl-CoA pathway, wherein said 6-aminocaproic acid pathway comprises at least one exogenous nucleic acid encoding a 6-aminocaproic acid pathway enzyme expressed in a sufficient amount to produce 6-aminocaproic acid, wherein said 6-aminocaproic acid pathway comprises a CoA-dependent aldehyde dehydrogenase; and a transaminase or a 6-aminocaproate dehydrogenase, wherein said transaminase converts adipate semialdehyde to 6-aminocaproic acid, wherein said adipyl-CoA pathway comprises at least one exogenous nucleic acid encoding an adipyl-CoA pathway enzyme expressed in a sufficient amount to produce adipyl-CoA, and wherein said adipyl-CoA pathway comprises alpha-ketoadipyl-CoA synthetase, phosphotransketoadipylase/alpha-ketoadipate kinase or alpha-ketoadipyl-CoA:acetyl-CoA transferase; 2-hydroxyadipyl-CoA dehydrogenase; 2-hydroxyadipyl-CoA dehydratase; and a 5-carboxy-2-pentenoyl-CoA reductase.

2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises one or two exogenous nucleic acids each encoding a 6-aminocaproic acid pathway enzyme.

3. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism further has a caprolactam pathway comprising at least one exogenous nucleic acid encoding a caprolactam pathway enzyme expressed in a sufficient amount to produce caprolactam, said caprolactam pathway comprising an amidohydrolase.

4. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises one, two, three, or four exogenous nucleic acids each encoding an adipyl-CoA pathway enzyme.

5. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid.

6. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a species of bacteria, yeast, or fungus.

7. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism is a species of bacteria selected from the group consisting of Escherichia coli, Klebsiella oxytoca, Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes, Mannheimia succiniciproducens, Rhizobium etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens , and Pseudomonas putida.

8. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism is a species of yeast or fungus selected from the group consisting of Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Aspergillus terreus, Aspergillus niger and Pichia pastoris.

9. The non-naturally occurring microbial organism of claim 8 , wherein the microbial organism is a species of Saccharomyces cerevisiae.

10. A method for producing 6-aminocaproic acid, comprising culturing the non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce 6-aminocaproic acid.

11. The method of claim 10 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.

12. The method of claim 10 , wherein said method further comprises separating the 6-aminocaproic acid from other components in the culture.

13. The method of claim 12 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, absorption chromatography, or ultrafiltration.

14. A method for producing caprolactam, comprising culturing the non-naturally occurring microbial organism of claim 3 under conditions and for a sufficient period of time to produce caprolactam.

15. The method of claim 14 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium.

16. The method of claim 14 , wherein said method further comprises separating the caprolactam from other components in the culture.

17. The method of claim 14 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, absorption chromatography, or ultrafiltration.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
Continuity (8)
Continuation 14450150 · Aug 1, 2014
Continuation 13452642 · Apr 20, 2012
Continuation 13288699 · Nov 3, 2011
Continuation 13088256 · Apr 15, 2011
Continuation 12875084 · Sep 2, 2010
Continuation 12413355 · Mar 27, 2009
Provisional Application 61040059 · Mar 27, 2008
Related Publication 20170130234A1 · May 11, 2017